Jones Financial Companies’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
7,579
+64
| +0.9% | +$8.07K | ﹤0.01% | 1020 |
|
|
2025
Q1 | $1.04M | Buy |
7,515
+2,550
| +51% | +$353K | ﹤0.01% | 844 |
|
|
2024
Q4 | $759K | Buy |
4,965
+1,346
| +37% | +$206K | ﹤0.01% | 837 |
|
|
2024
Q3 | $705K | Buy |
3,619
+2,120
| +141% | +$413K | ﹤0.01% | 711 |
|
|
2024
Q2 | $347K | Buy |
1,499
+1,330
| +787% | +$308K | ﹤0.01% | 658 |
|
|
2024
Q1 | $36.4K | Buy |
169
+165
| +4,125% | +$35.6K | ﹤0.01% | 789 |
|
|
2023
Q4 | $1.04K | Buy |
+4
| New | +$1.04K | ﹤0.01% | 962 |
|
|
2023
Q1 | – | Sell |
-6
| Closed | -$2K | – | 596 |
|
|
2022
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 595 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | -$6K | – | 730 |
|
|
2022
Q1 | $6K | Sell |
30
-130
| -81% | -$26K | ﹤0.01% | 552 |
|
|
2021
Q4 | $38K | Buy |
+160
| New | +$38K | ﹤0.01% | 396 |
|
|
2021
Q1 | – | Sell |
-123
| Closed | -$30K | – | 782 |
|
|
2020
Q4 | $30K | Buy |
+123
| New | +$30K | ﹤0.01% | 333 |
|
|
2013
Q4 | – | Sell |
-87
| Closed | -$21K | – | 257 |
|
|
2013
Q3 | $21K | Sell |
87
-1,037
| -92% | -$250K | ﹤0.01% | 409 |
|
|
2013
Q2 | $242K | Buy |
+1,124
| New | +$242K | ﹤0.01% | 202 |
|